Panacea Biotec

Panacea Biotec Join Forces with Refana To Develop COVID -19 Vaccine

The collaboration aims to bring to patients a whole inactivated virus-based vaccine for COVID-19. Under the collaboration, Panacea Biotec will be responsible for product development and commercial manufacturing with the joint venture undertaking clinical development and regulatory submissions across the world.